Nuzenio

Genmab As

Genmab As news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 11 publisher sources 100/100 entity strength

Latest news

GMAB Maintained by Guggenheim -- Price Target Raised to $42.00 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:16:06 GMTGenmab (CPSE:GMAB) Stock Revenue Strength Meets Profit Pressure - simplywall.stsimplywall.st · Fri, 07 Aug 2026 18:06:28 GMTGenmab: Q2 beat reinforces the investment story; diversification efforts remain on course - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 13:12:09 GMTGMAB Looks 19.0% Undervalued on GF Value™ as Shares Rally on Str - GuruFocusGuruFocus · Fri, 07 Aug 2026 09:29:07 GMTAnalyst notes several bright spots in guidance upgrade: "Genmab is focusing on the right areas" - medwatch.commedwatch.com · Fri, 07 Aug 2026 06:11:08 GMTGenmab (GMAB) Q2 2026 Earnings Call Transcript - The Motley FoolThe Motley Fool · Fri, 07 Aug 2026 01:52:00 GMTGenmab AS (GMAB) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo! Finance CanadaYahoo! Finance Canada · Thu, 06 Aug 2026 23:20:17 GMTGenmab stock falls despite H1 revenue rise - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 17:28:13 GMT

Timeline

Fri, 07 Aug 2026 19:16:06 GMTGMAB Maintained by Guggenheim -- Price Target Raised to $42.00 - GuruFocus
Fri, 07 Aug 2026 18:06:28 GMTGenmab (CPSE:GMAB) Stock Revenue Strength Meets Profit Pressure - simplywall.st
Fri, 07 Aug 2026 13:12:09 GMTGenmab: Q2 beat reinforces the investment story; diversification efforts remain on course - marketscreener.com
Fri, 07 Aug 2026 09:29:07 GMTGMAB Looks 19.0% Undervalued on GF Value™ as Shares Rally on Str - GuruFocus
Fri, 07 Aug 2026 06:11:08 GMTAnalyst notes several bright spots in guidance upgrade: "Genmab is focusing on the right areas" - medwatch.com
Fri, 07 Aug 2026 01:52:00 GMTGenmab (GMAB) Q2 2026 Earnings Call Transcript - The Motley Fool

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Genmab As.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.